z-logo
open-access-imgOpen Access
Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: Japan Phase 2 Study
Author(s) -
Mamoru Shibata,
Tomomi Nakamura,
Akichika Ozeki,
Kaname Ueda,
Richard D. Nichols
Publication year - 2020
Publication title -
journal of pain research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.888
H-Index - 49
ISSN - 1178-7090
DOI - 10.2147/jpr.s287781
Subject(s) - medicine , migraine , placebo , quality of life (healthcare) , clinical trial , pathology , alternative medicine , nursing
Evaluate changes from baseline in health-related quality of life (QoL) in Japanese patients with episodic migraine receiving preventive treatment with galcanezumab (GMB).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here